EGEIRO Pharma (XPAR:ALVET) Accumulated Depreciation : €-0.03 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is EGEIRO Pharma Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

EGEIRO Pharma's quarterly accumulated depreciation declined from Dec. 2022 (€-0.02 Mil) to Jun. 2023 (€0.00 Mil) but then increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€-0.03 Mil).

EGEIRO Pharma's annual accumulated depreciation increased from Dec. 2021 (€-0.01 Mil) to Dec. 2022 (€-0.02 Mil) and increased from Dec. 2022 (€-0.02 Mil) to Dec. 2023 (€-0.03 Mil).

EGEIRO Pharma Accumulated Depreciation Historical Data

The historical data trend for EGEIRO Pharma's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EGEIRO Pharma Accumulated Depreciation Chart

EGEIRO Pharma Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

-0.01

-0.02

-0.03

EGEIRO Pharma Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accumulated Depreciation	Get a 7-Day Free Trial					-	-0.02	-	-0.03	-

EGEIRO Pharma Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

EGEIRO Pharma Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of EGEIRO Pharma's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

EGEIRO Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EGEIRO Pharma (XPAR:ALVET) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Avenue Jean Mermoz 32/1, Gosselies, BEL, 6041

Website

https://www.egeiro.be

EGEIRO Pharma is a biopharmaceutical company. The company is focused on the clinical development of drugs for Idiopathic Pulmonary Fibrosis, a chronic, devastating, and fatal disease characterized by the deterioration of lung function.

EGEIRO Pharma Headlines

No Headlines